NIFTY50 and SENSEX fall over 1%, but Radico Khaitan, Max Financial, and Wockhardt hit 52-Week High

On Friday, 18 stocks advanced to 52-week highs. The benchmark indices, NIFTY50, slipped below 24,200 level, down 1%, and SENSEX was at 79,446, down 0.78%. The Nifty Bank was trading at 50,561, down 1.88%, while the fear gauge, India VIX, jumped by 6.30% to 14.82.

The broader market indices were in negative territory, with the Nifty Midcap 100 down 1.55% and the Nifty Smallcap 100 down 1.68%. The sectoral indices traded mixed, with Nifty FMCG up 1.3%, making it the top gainer. Meanwhile, Nifty PSU Bank was the top loser, falling by 2.17%.

Three stocks which hit fresh 52-week highs on Friday, October 25, 2024

Radico Khaitan Ltd

The company is one of the most recognized IMFL brands in India, incorporated in 1943.

On Friday, the stock surged by 9.92% from its previous close, reaching a 52-week high of ₹2,524. As of 13:30 p.m., it was trading at ₹2,232.30, up by 1.5%.

The company reported strong quarterly performance. EBITDA margins improved YoY to 14.6%, compared to 13.1% last year. Gross margins were impacted by food grain inflation, but premiumisation helped improve margins QoQ. The prestige and above segment volume stood at 3.2 million cases, a positive outcome.

In Q2 FY25, the company reported revenue of ₹1,116 crore, up from ₹925 crore in Q2 FY24, reflecting a YoY growth of 20.68%. PAT for Q2 FY25 was ₹82 crore, up from ₹62 crore in Q2 FY24.

Over the past month, the company has outperformed the market, delivering a return of 9.53%. Its current market capitalization stands at ₹31,367 crore.

Max Financial Services Ltd

The company focuses on business investments and providing management advisory services to Indian group companies.

On Friday, the stock surged by 14.48% from its previous close, reaching a 52-week high of ₹1,306.45. As of 13:30 p.m., it was trading at ₹1,266.05, up by 5.8%.

The company recently announced its results, showing revenue growth of 13.3% QoQ, though revenue remains below the March 2024 peak of ₹14,888 crore. Market participants expect positive momentum to continue. For 1HFY25, the company reported VNB (Value of New Business) growth of 16% YoY, driven by strong rider attachment growth.

In Q2 FY25, the company reported revenue of ₹13,372 crore, up from ₹10,165 crore in Q2 FY24, reflecting a YoY growth of 31.56%. PAT for Q2 FY25 stood at ₹139 crore, down from ₹170 crore (includes other income of ₹25 crore) in Q1 FY24.

Over the past month, the company has outperformed the market, delivering a return of 8.70%. Its current market capitalization stands at ₹44,616 crore.

Wockhardt Ltd

The company is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, orals, and topicals.

On Friday, the stock surged by 2.26% from its previous close, reaching a 52-week high of ₹1,146.80. As of 13:30 p.m., it was trading at ₹1,074.70, down by +0.45%.

The company demonstrated impressive EBITDA growth of 76% YoY in FY24 over FY23 and focused on reducing debt by ₹499 crore. Experts suggest that the momentum in the company's top-line growth could potentially continue under favorable conditions.The company has filed 3,265 patents, with 842 granted, and employs over 350 scientists.

In Q1 FY25, the company reported revenue of ₹739 crore, up from ₹644 crore in Q1 FY24, reflecting YoY growth of 14.75%. PAT for Q1 FY25 showed a loss of ₹16 crore, an improvement from a loss of ₹136 crore in Q1 FY24.

Over the past month, the company has outperformed the market, delivering a return of 6.98%. Its current market capitalization stands at ₹16,735 crore.